Table_3_Longitudinal Analysis of T and B Cell Receptor Repertoire Transcripts Reveal Dynamic Immune Response in COVID-19 Patients.xlsx by Xuefeng Niu (519266)

“…Panoramic concurrent assessment of BCR repertoires demonstrated isotype switching and a transient but dramatic early IgA expansion. Dominant B cell clonal expansion with decreased diversity occurred following recovery from infection. …”

Table_2_Longitudinal Analysis of T and B Cell Receptor Repertoire Transcripts Reveal Dynamic Immune Response in COVID-19 Patients.xlsx by Xuefeng Niu (519266)

“…Panoramic concurrent assessment of BCR repertoires demonstrated isotype switching and a transient but dramatic early IgA expansion. Dominant B cell clonal expansion with decreased diversity occurred following recovery from infection. …”

Table_3_Longitudinal Analysis of T and B Cell Receptor Repertoire Transcripts Reveal Dynamic Immune Response in COVID-19 Patients.xlsx by Xuefeng Niu (519266)

“…Panoramic concurrent assessment of BCR repertoires demonstrated isotype switching and a transient but dramatic early IgA expansion. Dominant B cell clonal expansion with decreased diversity occurred following recovery from infection. …”

Image_1_Longitudinal Analysis of T and B Cell Receptor Repertoire Transcripts Reveal Dynamic Immune Response in COVID-19 Patients.jpeg by Xuefeng Niu (519266)

“…Panoramic concurrent assessment of BCR repertoires demonstrated isotype switching and a transient but dramatic early IgA expansion. Dominant B cell clonal expansion with decreased diversity occurred following recovery from infection. …”

Example of host noncoding transcripts significantly upregulated or downregulated in infected samples compared to mock infection. by Seth B. Garren (799962)

AaERR directly regulates the expression of key enzymes in the CM pathway. by Dan-Qian Geng (18137370)

DataSheet_2_Epigenetic immune monitoring for COVID-19 disease course prognosis.zip by Björn Samans (7254668)

“…In venous blood, we detected relative lymphopenia, neutrophilia, and a decreased lymphocyte-to-neutrophil ratio for COVID-19 patients (n =103) when compared with healthy donors (n = 113). …”

DataSheet_1_Epigenetic immune monitoring for COVID-19 disease course prognosis.docx by Björn Samans (7254668)

“…In venous blood, we detected relative lymphopenia, neutrophilia, and a decreased lymphocyte-to-neutrophil ratio for COVID-19 patients (n =103) when compared with healthy donors (n = 113). …”

DataSheet_2_Epigenetic immune monitoring for COVID-19 disease course prognosis.zip by Björn Samans (7254668)

“…In venous blood, we detected relative lymphopenia, neutrophilia, and a decreased lymphocyte-to-neutrophil ratio for COVID-19 patients (n =103) when compared with healthy donors (n = 113). …”

DataSheet_1_Epigenetic immune monitoring for COVID-19 disease course prognosis.docx by Björn Samans (7254668)

“…In venous blood, we detected relative lymphopenia, neutrophilia, and a decreased lymphocyte-to-neutrophil ratio for COVID-19 patients (n =103) when compared with healthy donors (n = 113). …”

A Survey of the Vegetative Abundance, Diversity and Cover in Grasslands using Quadrat Measurements by Monica Matta (3120636)

Gene expression levels of the plasma membrane localized TLRs <i>Tlr1</i>, <i>Tlr2</i>, <i>Tlr4</i>, <i>Tlr5</i>, and <i>Tlr6</i> in different heart failure models of diverse etiolo... by Peter Moritz Becher (192666)

“…In STZ-induced diabetic cardiomyopathy (shown green), a decreased gene expression of <i>Tlr5</i> in comparison to their healthy controls was detected; the remaining plasma membrane localized TLRs displayed no changes in gene expression levels. …”

BioMedCentral APC fees - a comparison between 2012 & 2013 by Ross Mounce (96444)

“…<br><br>Of the 97 journals I've compared here (not all of them), the mean price increase is <strong>just over 5%</strong>.<br><br>To be fair to BMC, some of the biggest price hikes appear to be from society journals e.g. …”

AaERR directly regulates the expression of key enzymes in the LM pathway. by Dan-Qian Geng (18137370)

CRNN over-expression promotes the growth of cSCC xenografts in vivo. by Changji Li (4806930)

Supplementary file 4_Breast cancer burden in the United States (1990–2021) with a 15-year forecast: a comprehensive analysis based on the global burden of disease 2021.gif by Zhijian Huang (1649578)

“…Death rates fell from 15.9 (14.9–16.5)/100,000 to 9.4 (8.5–9.9)/100,000, while DALYs decreased from 485.1 (462.9–507.0)/100,000 to 277.4 (260.1–294.8)/100,000 over the same period. …”

Data Sheet 4_Breast cancer burden in the United States (1990–2021) with a 15-year forecast: a comprehensive analysis based on the global burden of disease 2021.csv by Zhijian Huang (1649578)

“…Death rates fell from 15.9 (14.9–16.5)/100,000 to 9.4 (8.5–9.9)/100,000, while DALYs decreased from 485.1 (462.9–507.0)/100,000 to 277.4 (260.1–294.8)/100,000 over the same period. …”

Supplementary file 1_Breast cancer burden in the United States (1990–2021) with a 15-year forecast: a comprehensive analysis based on the global burden of disease 2021.gif by Zhijian Huang (1649578)

“…Death rates fell from 15.9 (14.9–16.5)/100,000 to 9.4 (8.5–9.9)/100,000, while DALYs decreased from 485.1 (462.9–507.0)/100,000 to 277.4 (260.1–294.8)/100,000 over the same period. …”

Supplementary file 2_Breast cancer burden in the United States (1990–2021) with a 15-year forecast: a comprehensive analysis based on the global burden of disease 2021.gif by Zhijian Huang (1649578)

“…Death rates fell from 15.9 (14.9–16.5)/100,000 to 9.4 (8.5–9.9)/100,000, while DALYs decreased from 485.1 (462.9–507.0)/100,000 to 277.4 (260.1–294.8)/100,000 over the same period. …”

Supplementary file 3_Breast cancer burden in the United States (1990–2021) with a 15-year forecast: a comprehensive analysis based on the global burden of disease 2021.gif by Zhijian Huang (1649578)

“…Death rates fell from 15.9 (14.9–16.5)/100,000 to 9.4 (8.5–9.9)/100,000, while DALYs decreased from 485.1 (462.9–507.0)/100,000 to 277.4 (260.1–294.8)/100,000 over the same period. …”